Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
July 13 2022 - 8:00AM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform for
quantifying the proteome, today announced it will report
financial results for the second quarter 2022 before market open on
Tuesday, August 2nd, 2022.
The company’s management will webcast a
corresponding conference call beginning at 5:30 a.m. Pacific Time /
8:30 a.m. Eastern Time to discuss its results, business
developments, and outlook. Live audio of the webcast will be
available on the “Investors” section of the company website at:
www.nautilus.bio.
About Nautilus Biotechnology,
Inc.
Based in Seattle, Washington, Nautilus is a
development stage life sciences company creating a platform
technology for quantifying and unlocking the complexity of the
proteome. Nautilus’ mission is to transform the field of proteomics
by democratizing access to the proteome and enabling fundamental
advancements across human health and medicine. To learn more about
Nautilus, visit www.nautilus.bio.
Media contactThermal for Nautilus
BiotechnologyKaustuva Daspress@nautilus.bio
Investor
ContactinvestorRelations@nautilus.bio
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nautilus Biotechnology (NASDAQ:NAUT)
Historical Stock Chart
From Apr 2023 to Apr 2024